Table 3 Summary table of the significant immunohistochemistry results showing the regulatory effect
Receptor | LE | GE | Stroma | Myometrium | Blood Vessels |
|---|---|---|---|---|---|
EP1 | - | - | Increased (48EP) | Increased (48EP and 48PE) | - |
EP2 | Increased (1 and 5 μg E2 48 h, 2.5 μg E2 4 and 7 days) | Increased (5 μg E2 48 h 2.5 μg E2 4 and 7 days) | Increased (5 μg E2 24 h and 48 h, 2.5 μg E2 4 and 7 days) | Increased (5 μg E2 48 h, 2.5 μg E2 1, 4 and 7 days ) | Increased (2.5 μg E2, 7 days) |
EP3 | - | Increased (48EP) | Increased (2.5 μg E2 48 hrs; 48EP) | Increased (2.5 μg E2 48 hrs; 48EP) | - |
EP4 | - | - | Increased (5 μg E2 24 h) | - |